CERS
Cerus Corporation
NASDAQ · USHealthcareMedical - Devices
$3.15+0.64%
Price as of Jul 20, 2026
CERS valuation
Cerus Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.42x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.34x
- Price / sales
- 2.83x
- Price / cash flow
- 239.80x
Enterprise value
- Enterprise value
- $648.8M
- EV / sales
- 2.91x
- EV / EBITDA
- 545.23x
- EV / EBIT
- -36.67x
- Market cap
- $631.2M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.